Common and Severe Side Effects of Delta 9

Delta-9-tetrahydrocannabinol, the compound most people mean when they say “THC,” produces a predictable set of common side effects: dry mouth, red eyes, dizziness, drowsiness, increased heart rate, and anxiety. These are familiar enough that regular users barely register them. But delta-9 also carries rarer and more serious risks, from cardiovascular events and psychotic episodes to a stubborn vomiting syndrome that can land heavy users in the emergency room. How much trouble THC causes depends heavily on the dose, the route of consumption, how often you use it, and your own biology.

The Side Effects Nearly Everyone Notices

If you have used cannabis even once, you have probably experienced the cluster of mild effects that researchers consider the baseline response to delta-9. A systematic review of medicinal cannabis in fibromyalgia patients identified the most frequently reported adverse events as feeling “high,” dizziness or vertigo, dry mouth, cough, red eyes, and drowsiness, with no serious adverse events in that population.¹ Those same complaints show up across clinical trials regardless of why THC is being studied, which tells you they are pharmacological constants rather than quirks of a particular patient group.

Dry mouth happens because cannabinoid receptors sit on salivary glands and temporarily slow their output. Red eyes result from blood vessel dilation in the conjunctiva. Dizziness and drowsiness are central nervous system effects. None of these are dangerous in themselves, but they can be genuinely unpleasant for a first-time or low-tolerance user who was not expecting them. They also tend to fade as the acute high wears off, usually within a few hours for inhaled THC and somewhat longer for edibles.

Heart Rate and Blood Pressure Changes

One of the most consistent physiological responses to delta-9 is a spike in heart rate. In a controlled inhalation study, THC-dominant cannabis raised heart rate by roughly 16 to 17 beats per minute and bumped mean arterial pressure by about 5 to 7 mm Hg, regardless of whether participants smoked or vaped. CBD-dominant cannabis, by contrast, did not produce those changes.² The mechanism involves both sympathetic stimulation and parasympathetic inhibition of cardiovascular pathways, a finding established decades ago using autonomic blocking drugs.³

For a healthy young adult, a heart rate bump of 15 to 20 beats per minute is usually unremarkable. For someone with an existing heart condition, it is a different story. Observational data link marijuana use to a broad range of adverse cardiovascular outcomes.⁴ A recent meta-analysis of large population studies found that cannabis users had a roughly 71 percent higher risk of atrial arrhythmias compared with non-users.⁵ That does not mean every user is heading for a cardiac event, but people with heart rhythm disorders or hypertension should take the cardiovascular signal seriously.

An interesting wrinkle: the cardiovascular response to THC changes with prolonged use. Early research on hospitalized volunteers found that while a single dose produced the expected tachycardia and stable or increased blood pressure, prolonged daily THC ingestion actually produced heart rate slowing and blood pressure lowering.⁶ The body adapts, but that adaptation itself can produce orthostatic hypotension and lightheadedness, especially when standing up quickly.

Anxiety and Acute Psychiatric Reactions

Cannabis is often used to relax, which makes it confusing for people who instead experience a wave of anxiety or paranoia. THC increases anxiety in a dose-dependent fashion. In a controlled oral dosing study, THC raised heart rate, lowered a measure of parasympathetic cardiac control, and simultaneously increased subjective anxiety ratings, with the cardiac and anxiety responses tracking together.⁷ Lower doses may feel calming, but higher doses reliably push people in the other direction.

At the more severe end of the psychiatric spectrum, THC can induce transient psychotic symptoms. In an experimental study of healthy volunteers given intravenous delta-9, about 69 percent were classified as sensitive to psychosis-like effects based on standardized psychiatric rating scales. Those sensitive individuals showed an average increase of nearly 6 points on the primary psychosis symptom measure, compared with less than a 1-point increase for the rest.⁸ The psychotic symptoms were transient and resolved as the drug wore off, but for anyone with a personal or family history of psychotic illness, even brief episodes can be destabilizing. The same study found that people who were most susceptible to THC-induced psychosis had lower baseline levels of certain brain metabolites, suggesting an underlying neurochemical vulnerability.

Impaired Driving and Cognitive Performance

THC impairs the skills that driving demands. A systematic review and meta-analysis found that several measures of driving performance and driving-related cognitive skills, including lateral control, tracking, and divided attention, were significantly impaired at peak THC levels.⁹ Lateral control is the ability to keep a vehicle within its lane, which is exactly the kind of fine motor task that THC degrades.

What makes this tricky from a practical standpoint is that people who are high on cannabis often underestimate how impaired they are. Unlike alcohol, where slurred speech and obvious coordination loss provide some self-monitoring cues, cannabis impairment can feel subtle while still being measurable on a simulator or in a reaction-time test. The impairment is real and persists for several hours after inhalation, longer after edibles.

Cannabinoid Hyperemesis Syndrome

One of the more paradoxical side effects of heavy, long-term delta-9 use is cannabinoid hyperemesis syndrome, or CHS. Despite the fact that THC is frequently used to treat nausea, prolonged heavy use can flip the script and trigger cyclical episodes of severe nausea, violent vomiting, and intense abdominal pain. Symptoms typically start abruptly within 24 hours of the last cannabis use and last less than a week.¹⁰ A hallmark feature is that hot showers or baths provide temporary relief, which often leads to compulsive bathing.

The underlying mechanism appears to involve changes in the endocannabinoid system from prolonged high-dose THC exposure. Acting on the CB1 receptor over time, THC can dysregulate stress and anxiety responses, body temperature regulation, and several neurotransmitter systems.¹¹ CHS appears most strongly associated with frequent, long-term use of inhaled THC-dominant cannabis. A survey-based study found that smoking and vape cartridges were the most common consumption methods among CHS patients, and that vape cartridge use was associated with a shorter time to the development of symptoms.¹²

CHS is often misdiagnosed as cyclic vomiting syndrome or food poisoning, and some patients cycle through emergency rooms for months before the connection to cannabis is made. The only reliably effective treatment is stopping cannabis use entirely. People who resume heavy use after a CHS episode almost always relapse.

Respiratory Effects from Smoking

If you smoke cannabis regularly, you will eventually develop symptoms that look like chronic bronchitis: cough, excess mucus production, and wheezing. Cannabis smoke irritates the bronchial lining and produces histological signs of airway inflammation and tissue remodeling.¹³ Long-term cannabis smoking has also been associated with airflow obstruction, and there is some evidence linking it to macroscopic emphysema, though disentangling the contribution of cannabis from tobacco in people who use both is notoriously difficult.¹⁴

The somewhat reassuring finding is that the bronchitis-like symptoms tend to resolve after quitting, suggesting the damage is primarily inflammatory rather than structural.¹⁵ This makes cannabis-related airway disease quite different from the progressive structural destruction seen with heavy tobacco smoking. Switching to vaporizers or edibles sidesteps the combustion issue entirely, though vaping introduces its own set of unknowns.

Drug Interactions Worth Knowing About

Delta-9 THC is broken down in the liver by the same enzyme families that metabolize most prescription medications. A systematic review of cannabis-drug interactions highlighted CYP3A4, CYP2C9, and CYP2C19 as the shared pathways, predicting the potential for drug-drug interactions and adverse outcomes, especially for medications with a narrow therapeutic index.¹⁶ A narrow therapeutic index means that a small change in blood levels of the drug can flip it from therapeutic to toxic.

Laboratory work evaluating 12 different cannabinoids against major drug-metabolizing enzymes found that CYP2C9 was inhibited by nearly all of them at clinically relevant concentrations, while effects on CYP2D6, CYP1A2, and CYP3A4 were more limited.¹⁷ CYP2C9 handles the metabolism of drugs like warfarin, certain anti-seizure medications, and some nonsteroidal anti-inflammatory drugs. If you use THC regularly and take any of those, your drug levels could creep higher than expected. This is especially important for anyone on blood thinners, where a small rise in drug concentration can increase bleeding risk.

Tolerance, Dependence, and Withdrawal

Regular THC use builds tolerance to many of its effects. A systematic review of human evidence found that acute effects of cannabinoid administration were consistently less prominent in regular users compared to occasional or non-users. Cognitive function showed the highest degree of tolerance, with some evidence of full tolerance, meaning the acute impairment disappeared entirely. The intoxicating, psychosis-like, and cardiac effects were also blunted, though only partially.¹⁸

Tolerance develops because the brain’s CB1 receptors downregulate in response to chronic THC exposure. Brain imaging studies have confirmed this directly: chronic daily cannabis smokers show reduced CB1 receptor availability in cortical regions. The encouraging news is that this downregulation begins to reverse within just days of stopping, with significant recovery after roughly four weeks of abstinence in most brain regions, though the hippocampus may lag behind.¹⁹ A separate imaging study confirmed that CB1 receptor recovery begins rapidly after stopping and may continue to increase over time.²⁰

When heavy users stop, a recognized cannabis withdrawal syndrome can emerge. The most common features are anxiety, irritability, anger or aggression, disturbed sleep and vivid dreams, depressed mood, and loss of appetite.²¹ These symptoms are typically light to moderate in intensity and usually manageable without hospitalization.²² They are not medically dangerous in the way that alcohol or benzodiazepine withdrawal can be, but they are real enough to derail quit attempts. The sleep disruption in particular can persist for weeks and is often the symptom that drives people back to use.

Risks During Pregnancy

THC crosses the placenta, and the evidence consistently points toward harm. In a rhesus macaque model, chronic prenatal THC exposure significantly decreased amniotic fluid volume, placental perfusion, and fetal oxygen availability, all indicators of placental insufficiency. Placental tissue showed signs of ischemic injury with microinfarctions present only in the THC-exposed group.²³ Rat studies echo these findings, showing growth-restricted pups with decreased liver-to-body and brain-to-body weight ratios after THC exposure during pregnancy.²⁴

Human data tell a compatible story. A study tracking neonatal body composition found that babies with prenatal THC exposure had lower fat mass and adiposity at birth, and then experienced a faster-than-normal rise in BMI during their first three years, a pattern often associated with metabolic risk later in life.²⁵ Breastfeeding appeared to modify the association, with longer breastfeeding duration buffering the rapid BMI gain. No major medical organization currently considers cannabis use safe during pregnancy.

Accidental Ingestion in Children

With the expansion of legal cannabis markets and the proliferation of THC-containing edibles that look like candy or baked goods, accidental ingestion by young children has become a growing emergency-room concern. Children who accidentally eat THC edibles present differently from adults because of their smaller body size and developing nervous systems. Common symptoms include drowsiness and deep somnolence, nausea, and vomiting, but children are at high risk for more severe symptoms including respiratory depression and seizures.²⁶ Unintentional marijuana ingestion and severe toxicity in pediatric cases have been steadily increasing.

The practical takeaway for anyone with THC products in a household with children is straightforward: treat edibles the same way you would treat prescription medications. Locked storage, child-resistant packaging, and keeping products in their original labeled containers all reduce the risk. A toddler cannot distinguish a THC gummy from a regular one.

Adolescent Brain Vulnerability

The developing brain appears more susceptible to lasting THC-related changes than the adult brain. Animal research has shown that adolescent THC exposure leads to enhanced sensitivity to fear stimuli both behaviorally and at the level of neuronal signaling, with alterations in prefrontal cortex function mediated through changes in glutamate-dependent pathways.²⁷ Separate work in female rats found that adolescent THC treatment triggered a persistent neuroinflammatory state in the prefrontal cortex, with increased markers of inflammation and reduced anti-inflammatory signaling. Blocking the inflammatory response during THC treatment significantly reduced the resulting long-term memory impairments.²⁸

These are animal studies, and translating them directly to human teenagers requires caution. But they are consistent with the epidemiological observation that early-onset cannabis use is associated with poorer cognitive outcomes in adulthood. The prefrontal cortex is one of the last brain regions to finish maturing, a process that continues into the mid-twenties, which likely explains why adolescents are more vulnerable to THC’s disruptive effects on brain development.

How Synthetic Cannabinoids Compare

Products sometimes marketed as “synthetic THC” or sold under brand names like K2 and Spice are not the same molecule as delta-9-tetrahydrocannabinol. They are laboratory-made compounds that bind to the same cannabinoid receptors but are often far more potent and less predictable. A review from a public health perspective noted that synthetic cannabinoids replicate some effects of natural cannabis and THC but induce more severe adverse effects, including respiratory difficulties, hypertension, chest pain, muscle twitches, acute kidney failure, agitation, psychosis, and suicidal ideation.²⁹

The reason synthetic cannabinoids are so much more dangerous comes down to receptor pharmacology. Delta-9 THC behaves as a partial agonist at CB1 receptors in most brain circuits, meaning it activates the receptor but with a ceiling on how much activation it can produce. Synthetic cannabinoids are typically full agonists with no such ceiling, and their potency can be orders of magnitude higher. This is why fatal overdoses, which are essentially unheard of with plant-derived THC alone, have been documented with synthetic cannabinoids. If you encounter a product marketed as a legal alternative to marijuana, the risk profile is dramatically worse than anything associated with delta-9 itself.